Sensation: Indian HIV vaccine has proven safe
India has announced the first results of an unprecedented experiment. Indian professionals have completed the first phase of clinical trials of HIV vaccine. It is reported that the vaccine does not provoke the emergence of any side effects, said Xinhua.
According to the head of the Indian Council of Medical Research Dr. VM Katocha, the results are encouraging. "We hope that the vaccine will be able to help in the fight against the most common strains of the virus, which can be found in India. This testing – it does not require haste. We put at the heart of efficiency, not statistics," – says Dr. Katoch .
It is said that for India to develop its own vaccine against HIV is a priority matter, because the country is on the list of states with the highest percentage of HIV-infected people. In India, due to HIV affects about three million people.
HIV vaccine trials are taking place in Russia. Earlier we wrote that the State Research Center of Virology and Biotechnology "Vector" Rospotrebnadzor completed the vaccine "KombiVIChvak", and received permission to test it on volunteers. A Laboratory of Molecular Biology, Institute of Immunology HIV Russia closed the first phase of clinical vaccine trials "HIVREPOL."